ArticleEClinicalMedicine2025

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Paul Coppo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.